EVASENCEPriority claimed from 05/04/2011; Application No. : 85/287,171 ;United States ofAmerica (Class 5)
#2146170
Application Number:2146170
Status:
UNKNOWN
Class:5
Applicant: AFFYMAX PHARMA LTD
Filing Date:Wed, 18 May 2011
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | EVASENCEPriority claimed from 05/04/2011; Application No. : 85/287,171 ;United States ofAmerica |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 2146170 |
| Nature/Scope of business | PHARMACEUTICALS FOR USE IN STIMULATING HUMAN BLOOD CELL PRODUCTION; PHARMACEUTICALS FOR THE TREATMENT OF CANCER,ANEMIA,ISCHEMIA,MYOCARDIAL INFARCTION,CONGESTIVE HEART FAILURE,RENAL FAILURE, ANOXIA-INDUCED CELLULAR DEGENERATION,HYPOXIA-INDUCED CELLULAR DEGENERATION AND STROKE. |
| Publication | In Journal No. 1740 |
| Status | UNKNOWN |
| Applicant: | AFFYMAX PHARMA LTD |
| Applicant Address | THE BROADGATE TOWER 3RD FLOOR 20 PRIMROSE STREET LONDON EC2A 2RS UK MANUFACTURERS,TRADERS AND SERVICE PROVIDERS A UNITED KINGDOM LIMITED COMPANY |
| Jurisdiction | DELHI |
| Agent | ANAND AND ANAND. |
| Agent Address | B-41,NIZAMUDDIN EAST, NEW DELHI - 110 013. |
Frequently Asked Questions
What is the status of trademark EVASENCEPriority claimed from 05/04/2011; Application No. : 85/287,171 ;United States ofAmerica? ▾
The trademark application number 2146170 is currently marked as "UNKNOWN" in the official trademark registry.
Who is the owner of trademark EVASENCEPriority claimed from 05/04/2011; Application No. : 85/287,171 ;United States ofAmerica? ▾
The trademark application number 2146170 is owned by AFFYMAX PHARMA LTD.
Which class does trademark EVASENCEPriority claimed from 05/04/2011; Application No. : 85/287,171 ;United States ofAmerica belong to? ▾
Trademark application number 2146170 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 2146170? ▾
The trademark agent associated with application number 2146170 is ANAND AND ANAND..
Was trademark EVASENCEPriority claimed from 05/04/2011; Application No. : 85/287,171 ;United States ofAmerica published in the journal? ▾
Yes, trademark application number 2146170 was published in Journal No. 1740.
What is trademark EVASENCEPriority claimed from 05/04/2011; Application No. : 85/287,171 ;United States ofAmerica? ▾
Trademark application number 2146170 relates to "PHARMACEUTICALS FOR USE IN STIMULATING HUMAN BLOOD CELL PRODUCTION; PHARMACEUTICALS FOR THE TREATMENT OF CANCER,ANEMIA,ISCHEMIA,MYOCARDIAL INFARCTION,CONGESTIVE HEART FAILURE,RENAL FAILURE, ANOXIA-INDUCED CELLULAR DEGENERATION,HYPOXIA-INDUCED CELLULAR DEGENERATION AND STROKE.".
File Trademark at Just ₹1,999 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
10,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified